Synapse

  • About
  • FAQ
  • Reports
  • Contact Us
  • Memorial Sloan Kettering Cancer Center

  • Works
  • Groups
  • People
  • Publications
  • Publishers
Advanced
Search Within

Sarat Chandarlapaty

  • Home
  • Works
  • Groups
  • Dashboard
  1. "Pergamon-Elsevier Science Ltd"
Formats
  1. Meeting Abstract (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  2. Breast Medicine Service (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Genitourinary Oncology Service (1)
  6. Human Oncology and Pathogenesis Program (1)
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  2. Breast Medicine Service (1)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Genitourinary Oncology Service (1)
  6. Human Oncology and Pathogenesis Program (1)
  7. Molecular Pharmacology and Chemistry Program Faculty (1)
  8. Sloan Kettering Institute Faculty (1)
  9. Solid Tumor Oncology Division (1)

More Groups

Fewer Groups

People
  1. David Solit (1)
  2. Neal Rosen (1)
  3. Qing Ye (1)
Years
  1. 2006 (1)
Publications
  1. EJC Supplements (1)
Publishers
  1. Pergamon-Elsevier Science Ltd (1)

Results (1)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SNX5542, an oral Hsp90 inhibitor, causes Her2 degradation and inhibition of tumor growth in models of Her2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Ye, Q.; Huang, K.; Fadden, P.; Rosen, N.; Solit, D.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Follow Us on
    Memorial Sloan Kettering Cancer Center | Memorial Hospital for Cancer and Allied Diseases | Sloan Kettering Institute
    Gerstner Sloan Kettering Graduate School of Biomedical Sciences Patients & Caregivers

    Legal Disclaimer | Giving to the Library
    © 2025 Memorial Sloan Kettering Cancer Center Library